Japan Tissue Engineering Co., Ltd. (JP:7774) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Japan Tissue Engineering Co., Ltd. reported a decline in net sales and net income for the second quarter of FY2024 compared to the previous year, with net sales down by 6.8% and net income per share falling to -5.55 yen. Despite these setbacks, the company maintains a strong equity ratio of 90.3%, indicating financial stability. Looking ahead, the company forecasts a modest recovery in net sales and income for the full fiscal year, although net income is expected to decrease by 39.2% compared to the previous year.
For further insights into JP:7774 stock, check out TipRanks’ Stock Analysis page.